Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial
Volume
12
Pagination
1102 - 1107
DOI
10.4244/EIJY16M08_01
Journal
EUROINTERVENTION
Issue
ISSN
1774-024X